Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Androgens increase cervical cancer risk and affect its development.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Cured meats in Nigeria have high cadmium levels, posing health risks.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

Perhexiline can effectively target ovarian cancer cells left after treatment.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Post-orchidectomy semen has better DNA integrity for fertility treatments.

Nanoemulsions can effectively treat skin cancer with fewer side effects.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

The new drug delivery system effectively targets lung cancer cells.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.

Prostate size varies by ethnic group, age, residence, and blood glucose, but not by body measurements or fat.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Research on non-muscle invasive bladder cancer has increased, with the U.S. leading, and highlights effective treatments like BCG despite some side effects.

Reporter characteristics affect detection of hair loss from cancer therapy.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.